middle.news
Nyrada Launches Final Phase I Cohort for Xolatryp After Strong Safety Signals
9:22am on Monday 14th of July, 2025 AEST
•
Biotechnology
Read Story
Nyrada Launches Final Phase I Cohort for Xolatryp After Strong Safety Signals
9:22am on Monday 14th of July, 2025 AEST
Key Points
Final Phase I cohort (Cohort 6) for Xolatryp commenced
Safety Review Committee cleared progression after Cohort 5 data
Cohort 5 tested highest dose with no adverse safety signals
Cohort 6 doubles infusion duration to enhance pharmacokinetic data
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NYRADA (ASX:NYR)
OPEN ARTICLE